Advertisement
Advertisement

Read Now: TheBodyPRO.com Covers AIDS 2014

Cardiovascular Issues Can Affect Brain Health

October 4, 2012

 < Prev  |  1  |  2 


Bear in Mind

The design of this study was cross sectional; this is analogous to a snapshot in time. It can only provide a glimpse of the state of health of participants. There was no control or comparison group in the Italian study. Findings from a cross-sectional study are not definitive.

A more useful study would have been to recruit a larger number of participants, both HIV positive and HIV negative, to monitor and test them repeatedly over several years. This would be a study of a different design called a longitudinal study. However, longitudinal studies are expensive and sometimes difficult to recruit for and maintain. Cross-sectional studies can, however, provide limited findings that can be used to make the case for funding a longitudinal study.

Perhaps the most important finding from the Italian study is that cardiovascular disease risk can affect the workings of the brain, particularly the parts involved in memory and thinking in HIV-positive people. A similar effect has been observed in HIV-negative people. As ART enables HIV-positive people to live near-normal life spans, the focus of care may need to shift to monitoring for and treating the diseases of aging.

Other studies have also found an increased risk for CVD among HIV-positive people. In part, this may be a consequence of HIV infection and the persistent inflammation that this virus triggers. In experiments with monkeys infected with simian immunodeficiency virus (SIV, which can cause an AIDS-like disease in susceptible monkeys), researchers have found signs of premature cardiovascular disease. And another study by a team experienced in HIV brain research used MRIs and found a connection between problems controlling blood sugar and damage to structures deep within the brain.

All of this research underscores the need for longitudinal studies to assess the risk of CVD in HIV-positive people. It also highlights the necessity of potential interventions for people at risk for CVD with combinations of therapy (exercise, medicine, changes to the diet, help for smoking cessation, stress reduction and so on) so that health can be maintained or improved. Moreover, by preventing and treating co-morbidities, the research team suggests that, in theory, doctors may be able to reverse the mild neurocognitive impairment that seems to be relatively common in studies with HIV-positive people in the present era.


Resources


References

  1. Heaton RK, Franklin DR, Ellis RJ, et al. HIV-associated neurocognitive disorders before and during the era of combination antiretroviral therapy: differences in rates, nature, and predictors. Journal of Neurovirology. 2011 Feb;17(1):3-16.
  2. Fabbiani M, Ciccarelli N, Tana M, et al. Cardiovascular risk factors and carotid intima-media thickness are associated with lower cognitive performance in HIV-infected patients. HIV Medicine. 2012; in press.
  3. McCrimmon RJ, Ryan CM, Frier BM. Diabetes and cognitive dysfunction. Lancet. 2012 Jun 16;379(9833):2291-9.
  4. Peters R. Blood pressure, smoking and alcohol use, association with vascular dementia. Experimental Gerontology. 2012; in press.
  5. Arntzen KA, Schirmer H, Johnsen SH, et al. Carotid artery plaque progression and cognitive decline: the Tromsø Study 1994-2008. European Journal of Neurology. 2012 Oct;19(10):1318-24.
  6. Beason-Held LL, Thambisetty M, Deib G, et al. Baseline cardiovascular risk predicts subsequent changes in resting brain function. Stroke. 2012 Jun;43(6):1542-7.
  7. Davenport MH, Hogan DB, Eskes GA, et al. Cerebrovascular reserve: the link between fitness and cognitive function? Exercise and Sport Sciences Reviews. 2012 Jul;40(3):153-8.
  8. Cruse B, Cysique LA, Markus R, et al. Cerebrovascular disease in HIV-infected individuals in the era of highly active antiretroviral therapy. Journal of Neurovirology. 2012 Aug;18(4):264-76.
  9. McCutchan JA, Marquie-Beck JA, Fitzsimons CA, et al. Role of obesity, metabolic variables, and diabetes in HIV-associated neurocognitive disorder. Neurology. 2012 Feb 14;78(7):485-92.
  10. Pandrea I, Cornell E, Wilson C, et al. Coagulation biomarkers predict disease progression in SIV-infected nonhuman primates. Blood. 2012; in press.
  11. Kelly KM, Tarwater PM, Karper JM, et al. Diastolic dysfunction is associated with myocardial viral load in simian immunodeficiency virus-infected macaques. AIDS. 2012 Apr 24;26(7):815-23.
  12. George MP, Brower A, Kling H, et al. Pulmonary vascular lesions are common in SIV- and SHIV-env-infected macaques. AIDS Research and Human Retroviruses. 2011 Feb;27(2):103-11.
  13. Asztalos BF, Mujawar Z, Morrow MP, et al. Circulating Nef induces dyslipidemia in simian immunodeficiency virus-infected macaques by suppressing cholesterol efflux. Journal of Infectious Diseases. 2010 Aug 15;202(4):614-23.
  14. Cattie JE, Doyle K, Weber E, et al. Planning deficits in HIV-associated neurocognitive disorders: Component processes, cognitive correlates, and implications for everyday functioning. Journal of Clinical and Experimental Neuropsychology. 2012; in press.
  15. Gerena Y, Skolasky RL, Velez JM, et al. Soluble and cell-associated insulin receptor dysfunction correlates with severity of HAND in HIV-infected women. PLoS One. 2012;7(5):e37358.
  16. Nakamoto BK, Jahanshad N, McMurtray A, et al. Cerebrovascular risk factors and brain microstructural abnormalities on diffusion tensor images in HIV-infected individuals. Journal of Neurovirology. 2012 Aug;18(4):303-12.
  17. Kamat A, Lyons JL, Misra V, et al. Monocyte activation markers in cerebrospinal fluid associated with impaired neurocognitive testing in advanced HIV infection. Journal of Acquired Immune Deficiency Syndromes. 2012 Jul 1;60(3):234-43.
  18. Towgood KJ, Pitkanen M, Kulasegaram R, et al. Regional cerebral blood flow and FDG uptake in asymptomatic HIV-1 men. Human Brain Mapping. 2012; in press.
  19. Ances BM, Ortega M, Vaida F, et al. Independent effects of HIV, aging, and HAART on brain volumetric measures. Journal of Acquired Immune Deficiency Syndromes. 2012 Apr 15;59(5):469-77.
  20. Fritsch T, McClendon MJ, Smyth KA, et al. Cognitive functioning in healthy aging: the role of reserve and lifestyle factors early in life. Gerontologist. 2007 Jun;47(3):307-22.
  21. Hall CB, Lipton RB, Sliwinski M, et al. Cognitive activities delay onset of memory decline in persons who develop dementia. Neurology. 2009 Aug 4;73(5):356-61.
  22. Foley JM, Ettenhofer ML, Kim MS, et al. Cognitive reserve as a protective factor in older HIV-positive patients at risk for cognitive decline. Applied Neuropsychology. 2012 Jan;19(1):16-25.
 < Prev  |  1  |  2 



This article was provided by Canadian AIDS Treatment Information Exchange. Visit CATIE's Web site to find out more about their activities, publications and services.
 

No comments have been made.
 

Add Your Comment:
(Please note: Your name and comment will be public, and may even show up in
Internet search results. Be careful when providing personal information! Before
adding your comment, please read TheBody.com's Comment Policy.)

Your Name:


Your Location:

(ex: San Francisco, CA)

Your Comment:

Characters remaining:

Advertisement